富蘭克林坦伯頓全球投資系列-亞洲小型企業基金美元A (acc)股
64.08美元0.1(0.16%)
2024/12/20更新
該基金的首要投資目標為提供長線資本增值。該基金主要投資於:(i) 在亞洲地區成立或 (ii) 其主要業務在亞洲地區進行的小型公司的可轉讓股票證券及預託證券。該基金可合共投資最高達其資產淨值的 20%於中國 A 股及中國 B 股。為增加額外資本或收益或為降低成本或風險,該基金可以符合其投資政策的方式從事證券借貸交易,最高可達其資產淨值的 50%。
大型 | |||
---|---|---|---|
中型 | |||
小型 | |||
價值型 | 均衡型 | 增長型 |
Vikas Chiranewal is a senior executive director with research responsibilities for companies in India and small cap companies across global emerging markets (GEM). In his role as a senior research team member for the GEM/Asia small cap strategy, he is responsible for generating new ideas, coordinating small cap research efforts and leveraging group's resources to add value across funds within the GEM/Asia small cap strategies. Mr. Chiranewal also manages Templeton India Growth Fund and Templeton India Equity Income Fund. Prior to joining Franklin Templeton in 2006, Mr. Chiranewal was a senior associate for Morgan Stanley's equity research team. Before his post-graduate diploma, he worked for McKinsey & Co.'s global research team. Mr. Chiranewal holds a bachelor's degree in commerce from Delhi university and a post graduate diploma in management from the Indian Institute of Management in Lucknow. He is a Chartered Financial Analyst (CFA) charterholder.
Krzysztof Musialik is a senior vice president and senior executive director with research responsibilities for companies in the Pharmaceuticals/Biotechnology sector across global emerging markets. Prior to joining Franklin Templeton in 2006, Mr. Musialik worked for BDO, an audit firm. He entered the financial services industry in 2006. Mr. Musialik graduated in international economics from the Katowice School of Economics and in international business from Toulouse Business School (Ecole Superieure de Commerce de Toulouse). He is a Chartered Financial Analyst (CFA) charterholder and holds an investment advisor license from the Polish Securities and Exchange Commission. Mr. Musialik speaks Polish, English and French.